Clinical Trial Update: Study of Weekly DCF to Treat Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating weekly DCF (docetaxel, cisplatin, and 5-fluorouracil) for advanced gastric cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Fudan University | Conditions: Gastric Cancer | Phase 2 | Status: TERMINATED